Efficacy and Safety of Rituximab Biosimilars in Treating Immune Thrombocytopenia HCP Live, 15 May 2023 Arthur Mageau, PhD Credit: LinkedIn The results of an observational study suggested that rituximab biosimilars, Rixathon and…